Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Orgenesis Inc

ORGS
0,5798
0,0398 (7,37%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/6/202414:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/6/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
11/6/202422:05EDGAR2Form 8-K - Current report
06/6/202422:05EDGAR2Form S-3 - Registration statement under Securities Act of..
31/5/202412:14EDGAR2Form 8-K - Current report
24/5/202415:16EDGAR2Form S-3/A - Registration statement under Securities Act of..
23/5/202414:00EDGAR2Form 8-K - Current report
21/5/202413:00GLOBEOrgenesis Provides Business Update for the First Quarter of..
20/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
06/5/202421:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/5/202421:26EDGAR2Form DEF 14A - Other definitive proxy statements
15/4/202423:07GLOBEOrgenesis Provides Year End Business Update
10/4/202418:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
18/3/202413:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
13/3/202413:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
04/3/202414:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
29/2/202414:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
31/1/202415:20EDGAR2Form 8-K - Current report
31/1/202415:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
24/1/202422:05EDGAR2Form 8-K - Current report
22/1/202422:01EDGAR2Form 8-K - Current report
08/1/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202412:02EDGAR2Form 8-K - Current report
14/11/202314:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
13/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/11/202315:24EDGAR2Form 8-K - Current report
08/11/202315:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
02/11/202313:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
31/10/202302:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
30/10/202321:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
21/9/202314:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
06/9/202313:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
05/9/202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202313:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
10/8/202323:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
13/7/202314:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
12/7/202322:05EDGAR2Form 8-K - Current report
11/7/202313:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
Apertura: 0,55 Min: 0,5498 Max: 0,58
Chiusura: 0,54

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network